Copyright Reports & Markets. All rights reserved.

Global Pregabalin Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Pregabalin Market Overview

      • 1.1 Product Overview and Scope of Pregabalin
      • 1.2 Pregabalin Segment by Type
        • 1.2.1 Global Pregabalin Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Epilepsy
        • 1.2.3 Neuropathic Pain
        • 1.2.4 Fibromyalgia
        • 1.2.5 Generalized Anxiety Disorder
      • 1.3 Pregabalin Segment by Application
        • 1.3.1 Pregabalin Consumption Comparison by Application (2014-2025)
        • 1.3.2 Research Institutes
        • 1.3.3 Pharmaceutical Companies
        • 1.3.4 Others (Hospitals and Clinics)
      • 1.4 Global Pregabalin Market by Region
        • 1.4.1 Global Pregabalin Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Pregabalin Market Size
        • 1.5.1 Global Pregabalin Revenue (2014-2025)
        • 1.5.2 Global Pregabalin Production (2014-2025)

      2 Global Pregabalin Market Competition by Manufacturers

      • 2.1 Global Pregabalin Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Pregabalin Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Pregabalin Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Pregabalin Production Sites, Area Served, Product Types
      • 2.5 Pregabalin Market Competitive Situation and Trends
        • 2.5.1 Pregabalin Market Concentration Rate
        • 2.5.2 Pregabalin Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Pregabalin Production Market Share by Regions

      • 3.1 Global Pregabalin Production Market Share by Regions
      • 3.2 Global Pregabalin Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Pregabalin Production
        • 3.4.1 North America Pregabalin Production Growth Rate (2014-2019)
        • 3.4.2 North America Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Pregabalin Production
        • 3.5.1 Europe Pregabalin Production Growth Rate (2014-2019)
        • 3.5.2 Europe Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Pregabalin Production (2014-2019)
        • 3.6.1 China Pregabalin Production Growth Rate (2014-2019)
        • 3.6.2 China Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Pregabalin Production (2014-2019)
        • 3.7.1 Japan Pregabalin Production Growth Rate (2014-2019)
        • 3.7.2 Japan Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Pregabalin Consumption by Regions

      • 4.1 Global Pregabalin Consumption by Regions
      • 4.2 North America Pregabalin Consumption (2014-2019)
      • 4.3 Europe Pregabalin Consumption (2014-2019)
      • 4.4 China Pregabalin Consumption (2014-2019)
      • 4.5 Japan Pregabalin Consumption (2014-2019)

      5 Global Pregabalin Production, Revenue, Price Trend by Type

      • 5.1 Global Pregabalin Production Market Share by Type (2014-2019)
      • 5.2 Global Pregabalin Revenue Market Share by Type (2014-2019)
      • 5.3 Global Pregabalin Price by Type (2014-2019)
      • 5.4 Global Pregabalin Production Growth by Type (2014-2019)

      6 Global Pregabalin Market Analysis by Applications

      • 6.1 Global Pregabalin Consumption Market Share by Application (2014-2019)
      • 6.2 Global Pregabalin Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Pregabalin Business

      • 7.1 Pfizer Inc.
        • 7.1.1 Pfizer Inc. Pregabalin Production Sites and Area Served
        • 7.1.2 Pregabalin Product Introduction, Application and Specification
        • 7.1.3 Pfizer Inc. Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Torrent Pharmaceuticals Ltd.
        • 7.2.1 Torrent Pharmaceuticals Ltd. Pregabalin Production Sites and Area Served
        • 7.2.2 Pregabalin Product Introduction, Application and Specification
        • 7.2.3 Torrent Pharmaceuticals Ltd. Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Lupin Limited
        • 7.3.1 Lupin Limited Pregabalin Production Sites and Area Served
        • 7.3.2 Pregabalin Product Introduction, Application and Specification
        • 7.3.3 Lupin Limited Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Zydus Cadila Healthcare Ltd.
        • 7.4.1 Zydus Cadila Healthcare Ltd. Pregabalin Production Sites and Area Served
        • 7.4.2 Pregabalin Product Introduction, Application and Specification
        • 7.4.3 Zydus Cadila Healthcare Ltd. Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Cipla Limited
        • 7.5.1 Cipla Limited Pregabalin Production Sites and Area Served
        • 7.5.2 Pregabalin Product Introduction, Application and Specification
        • 7.5.3 Cipla Limited Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Genesis Remedies
        • 7.6.1 Genesis Remedies Pregabalin Production Sites and Area Served
        • 7.6.2 Pregabalin Product Introduction, Application and Specification
        • 7.6.3 Genesis Remedies Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanofi
        • 7.7.1 Sanofi Pregabalin Production Sites and Area Served
        • 7.7.2 Pregabalin Product Introduction, Application and Specification
        • 7.7.3 Sanofi Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Medley Pharmaceuticals Limited
        • 7.8.1 Medley Pharmaceuticals Limited Pregabalin Production Sites and Area Served
        • 7.8.2 Pregabalin Product Introduction, Application and Specification
        • 7.8.3 Medley Pharmaceuticals Limited Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Genesis Biotec Inc.
        • 7.9.1 Genesis Biotec Inc. Pregabalin Production Sites and Area Served
        • 7.9.2 Pregabalin Product Introduction, Application and Specification
        • 7.9.3 Genesis Biotec Inc. Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Biomax
        • 7.10.1 Biomax Pregabalin Production Sites and Area Served
        • 7.10.2 Pregabalin Product Introduction, Application and Specification
        • 7.10.3 Biomax Pregabalin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Pregabalin Manufacturing Cost Analysis

      • 8.1 Pregabalin Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Pregabalin
      • 8.4 Pregabalin Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Pregabalin Distributors List
      • 9.3 Pregabalin Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Pregabalin Market Forecast

      • 11.1 Global Pregabalin Production, Revenue Forecast
        • 11.1.1 Global Pregabalin Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Pregabalin Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Pregabalin Price and Trend Forecast (2019-2025)
      • 11.2 Global Pregabalin Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Pregabalin Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Pregabalin Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Pregabalin Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Pregabalin Production, Revenue Forecast (2019-2025)
      • 11.3 Global Pregabalin Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Pregabalin Consumption Forecast (2019-2025)
        • 11.3.2 Europe Pregabalin Consumption Forecast (2019-2025)
        • 11.3.3 China Pregabalin Consumption Forecast (2019-2025)
        • 11.3.4 Japan Pregabalin Consumption Forecast (2019-2025)
      • 11.4 Global Pregabalin Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Pregabalin Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
        Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 

        The global Pregabalin market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Pregabalin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pregabalin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer Inc.
        Torrent Pharmaceuticals Ltd.
        Lupin Limited
        Zydus Cadila Healthcare Ltd.
        Cipla Limited
        Genesis Remedies
        Sanofi
        Medley Pharmaceuticals Limited
        Genesis Biotec Inc.
        Biomax

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Epilepsy
        Neuropathic Pain
        Fibromyalgia
        Generalized Anxiety Disorder

        Segment by Application
        Research Institutes
        Pharmaceutical Companies
        Others (Hospitals and Clinics)

        Buy now